2-200957500-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000234296.7(ORC2):āc.139A>Cā(p.Lys47Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000975 in 1,611,082 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000234296.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ORC2 | NM_006190.5 | c.139A>C | p.Lys47Gln | missense_variant | 4/18 | ENST00000234296.7 | NP_006181.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ORC2 | ENST00000234296.7 | c.139A>C | p.Lys47Gln | missense_variant | 4/18 | 1 | NM_006190.5 | ENSP00000234296 | P1 | |
ORC2 | ENST00000410039.5 | c.139A>C | p.Lys47Gln | missense_variant | 4/5 | 5 | ENSP00000386390 | |||
ORC2 | ENST00000457595.1 | c.139A>C | p.Lys47Gln | missense_variant | 4/4 | 2 | ENSP00000396641 | |||
ORC2 | ENST00000467605.5 | n.285A>C | non_coding_transcript_exon_variant | 3/5 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000985 AC: 15AN: 152222Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000108 AC: 27AN: 249264Hom.: 0 AF XY: 0.000104 AC XY: 14AN XY: 134888
GnomAD4 exome AF: 0.0000973 AC: 142AN: 1458860Hom.: 0 Cov.: 30 AF XY: 0.0000964 AC XY: 70AN XY: 725840
GnomAD4 genome AF: 0.0000985 AC: 15AN: 152222Hom.: 0 Cov.: 32 AF XY: 0.0000941 AC XY: 7AN XY: 74372
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 11, 2022 | The c.139A>C (p.K47Q) alteration is located in exon 4 (coding exon 2) of the ORC2 gene. This alteration results from a A to C substitution at nucleotide position 139, causing the lysine (K) at amino acid position 47 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at